Veredus Laboratories announced that it has developed a kit to diagnose Wuhan Coronavirus. It should be marketed by February 1 of this year.
Veredus Laboratories, a Singapore-based company that produces innovative molecular diagnostic solutions, has developed VereCoV, a portable Lab-on-Chip application that can detect in about two hours the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the 2019 (2019-nCoV) Wuhan Coronavirus Novel Coronavirus.
The VereCoV diagnosis kit is based on VereChip technology, a Lab-on-Chip platform that integrates two powerful molecular biology applications, Polymerase Chain Reaction (PCR) and microarray, capable of identifying and differentiating MERS-CoV, SARS-CoV and 2019-nCoV with high specificity and sensitivity.
Veredus Laboratories also produces chips that test for Zika and Dengue viruses. The company was founded by Dr. Tan in 2003 and is now owned by the Japanese plastics giant Sekisui Chemical.
Digital-health 